ZIPRASIDONE-ZP ziprasidone (as hydrochloride) 20 mg capsule blister pack

Active ingredient:

ziprasidone hydrochloride, Quantity: 21.72 mg (Equivalent: ziprasidone, Qty 20 mg)

Available from:

Medis Pharma Pty Ltd

INN (International Name):

Ziprasidone hydrochloride

Pharmaceutical form:

Capsule, hard

Composition:

Excipient Ingredients: Gelatin; pregelatinised maize starch; indigo carmine; magnesium stearate; colloidal anhydrous silica; titanium dioxide; croscarmellose sodium; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; Shellac; strong ammonia solution; ethanol absolute; iron oxide black

Administration route:

Oral

Units in package:

60

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

for the treatment of schizophrenia, related psychoses, prevention of relapse and for maintenance of clinical improvement during continuation therapy;,as monotherapy for the short term treatment of acute manic or mixed episodes associated with bipolar I disorder.

Product summary:

Visual Identification: size 4 capsule: white body, blue cap; "Z20" printed on capsule body; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure

Authorization status:

Licence status A

Authorization date:

2015-03-05